High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy

Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy

(2011) Fabian Schnitzler et al.   INFLAMMATORY BOWEL DISEASES

Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's Disease

(2010) Kuldeep Cheent et al.   Journal of Crohns & Colitis

An interspecies comparison of placental antibody transfer: New insights into developmental toxicity testing of monoclonal antibodies

(2009) Nele Pentšuk et al.   BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY

Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding

(2009) Javier P. Gisbert   INFLAMMATORY BOWEL DISEASES

Absence of Infliximab in Infants and Breast Milk From Nursing Mothers Receiving Therapy for Crohnʼs Disease Before and After Delivery

(2009) Sunanda Kane et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

(2009) Gert Van Assche et al.   Journal of Crohns & Colitis

Reproductive wish represents an important factor influencing therapeutic strategy in inflammatory bowel diseases

(2009) Zuzana Zelinkova et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn

(2009) Kristi Baker et al.   Seminars in Immunopathology

Placental Transport of Immunoglobulins: A Clinical Review for Gastroenterologists Who Prescribe Therapeutic Monoclonal Antibodies to Women During Conception and Pregnancy

(2008) Sunanda V Kane et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

499 The Effect of Maternal Peripartum Infliximab Use On Neonatal Immune Response

(2008) Uma Mahadevan et al.   GASTROENTEROLOGY